Toggle navigation
Home
Search
Services
Blog
Contact
About
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul
Yale University, New Haven, CT, United States
Search 3 grants from Paul Lebowitz
Search grants from Yale University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Studying the PhilAdelphia Resilience Project as a Response to Overdose (SPARRow)
Role of EZH2 in Breast Cancer Progression
The BEACON Coalition's DFC Project
Leukoencephalopathy in HAART-treated HIV-1+ Patients
1994 Presidential Awardees
Recently added grants:
Mapping superior colliculus contributions to action selection and movement
Prostate cancer-associated SPOP mutations modulate innate immune response and immune checkpoint therapy
Center for Pre-Clinical Cancer Research
Alterations and Renovation
Administration Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA049238-02
Application #
3193270
Study Section
Pathology B Study Section (PTHB)
Project Start
1989-01-09
Project End
1991-12-31
Budget Start
1990-01-01
Budget End
1990-12-31
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Institution
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Related projects
NIH 1991
R01 CA
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul / Yale University
NIH 1990
R01 CA
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul / Yale University
NIH 1989
R01 CA
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul / Yale University
Publications
Morris, S W; Daniel, L; Ahmed, C M et al.
(1990)
Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.
Blood 75:2035-41
Comments
Be the first to comment on Paul Lebowitz's grant